These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 1331757

  • 1. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.
    Gucker S, Bidlack JM.
    Mol Pharmacol; 1992 Oct; 42(4):656-65. PubMed ID: 1331757
    [Abstract] [Full Text] [Related]

  • 2. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Hom DS, Loh HH.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
    [Abstract] [Full Text] [Related]

  • 4. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC, Loh HH, Law PY.
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [Abstract] [Full Text] [Related]

  • 5. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY, Hom DS, Loh HH.
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [Abstract] [Full Text] [Related]

  • 6. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 7. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
    Belcheva MM, Barg J, Gloeckner C, Gao XM, Chuang DM, Coscia CJ.
    Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
    [Abstract] [Full Text] [Related]

  • 8. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L, Lowe VC, Kinnier WJ, U'Prichard DC.
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [Abstract] [Full Text] [Related]

  • 9. Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells.
    Morikawa H, Fukuda K, Mima H, Shoda T, Kato S, Mori K.
    Br J Pharmacol; 1998 Mar; 123(6):1111-8. PubMed ID: 9559894
    [Abstract] [Full Text] [Related]

  • 10. Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.
    Chen CC, Chang J, Chen WC.
    Mol Pharmacol; 1995 Jul; 48(1):39-47. PubMed ID: 7623773
    [Abstract] [Full Text] [Related]

  • 11. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
    Jin W, Lee NM, Loh HH, Thayer SA.
    Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
    [Abstract] [Full Text] [Related]

  • 12. Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells.
    Shahabi NA, Sharp BM.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):276-81. PubMed ID: 8380863
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
    Belcheva MM, Barg J, McHale RJ, Gao XM, Chuang DM, Coscia CJ.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):302-9. PubMed ID: 1656025
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [Abstract] [Full Text] [Related]

  • 15. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 16. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T, Wüster M, Gramsch C, Herz A.
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [Abstract] [Full Text] [Related]

  • 17. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of 5-hydroxytryptamine-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal smooth muscle cells by phorbol ester.
    Yang CM, Fen LW, Tsao HL, Chiu CT.
    Br J Pharmacol; 1997 Jul; 121(5):853-60. PubMed ID: 9222540
    [Abstract] [Full Text] [Related]

  • 19. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL, Loh HH, Law PY.
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.